---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-23-000208"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T20:45:39.211026+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Globus Medical Q1 net sales up 20% to $276.7M; non-GAAP EPS $0.53

## Summary
- Worldwide net sales $276.7M, up 20% YoY (21% constant currency); GAAP net income $49.1M.
- GAAP diluted EPS $0.48; non-GAAP diluted EPS $0.53, up 24.7% YoY.
- U.S. Spine sales up 14%; Enabling Technologies grew 91% to $25M.
- Full-year 2023 guidance reaffirmed: net sales $1.1B, non-GAAP diluted EPS $2.30.
- Pending merger with NuVasive received shareholder approvals from both companies.

## SEC filing metadata
- accession: 0001562762-23-000208
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000208/0001562762-23-000208-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000208/gmed-20230504x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-23-000208
- JSON: https://secwatch.observer/filing/0001562762-23-000208.json
- Plain text: https://secwatch.observer/filing/0001562762-23-000208.txt

## Key facts
- Earnings Releases
  GLOBUS MEDICAL INC reported three-month period ended March 31, 2023 results: revenue $276.7 million, net income $49.1 million, EPS $0.48.
  - Period: three-month period ended March 31, 2023
  - Revenue: $276.7 million
  - Net income: $49.1 million
  - EPS: $0.48
  - Result: reported results
  source text: · Worldwide net sales were $276.7 million , an increase of 20.0% , or 21.0% on a constant currency basis · GAAP net income for the quarter was $49.1 million · GAAP d iluted earnings per share (“ EPS ”) was $0.48
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000208/0001562762-23-000208-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.